Anika Therapeutics (ANIK) Total Debt (2010 - 2022)

Anika Therapeutics (ANIK) has 7 years of Total Debt data on file, last reported at $4.3 million in Q2 2022.

• Total Debt for Q2 2022 came in at $4.3 million, down 74.42% year-over-year; the trailing twelve-month figure through Jun 2022 was $4.3 million (down 74.42% YoY), and the FY2021 annual result was $4.3 million, down 67.04% from the prior year.
• Total Debt held at $4.3 million in Q2 2022 per ANIK's latest filing, from $4.3 million in the prior quarter.
• Over five years, Total Debt peaked at $50.0 million in Q2 2020 and troughed at $4.3 million in Q3 2021.
• A 3-year average of $16.3 million and a median of $13.1 million in 2020 frame the typical range for Total Debt.
• On a YoY basis, Total Debt climbed as much as 66.26% in 2021 and fell as far as 82.8% in 2021.
• A 3-year view of Total Debt shows it stood at $13.1 million in 2020, then sank by 67.04% to $4.3 million in 2021, then changed by 0.0% to $4.3 million in 2022.
• Business Quant data shows ANIK's Total Debt at $4.3 million in Q2 2022, $4.3 million in Q1 2022, and $4.3 million in Q4 2021.